See every side of every news story
Get Started
SubscribeLogin
Pope Francis
Vatican
Olaf Scholz
Volodymyr Zelenskyy
Ukraine War
Donald Trump
German Politics
Israel-Hamas Conflict
Tennis
Basketball
Baseball
Elon Musk
Published • loading... • Updated

Cagent Vascular launches Serranator SL-PRO for CLTI and pedal disease - Interventional News

Summary by Interventional News
Michael Lichtenberg Cagent Vascular has announced the launch of the Serranator SL-PRO percutaneous transluminal angioplasty (PTA) serration balloon catheter for chronic limb-threatening ischaemia (CLTI) and pedal disease. A press release notes that Serranator SL-PRO utilises Cagent’s proven serration technology on a redesigned platform, offering improved deliverability and trackability, while offering Serranator’s proven 1,000 times increase in …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Interventional NewsInterventional News

Cagent Vascular launches Serranator SL-PRO for CLTI and pedal disease - Interventional News

Michael Lichtenberg Cagent Vascular has announced the launch of the Serranator SL-PRO percutaneous transluminal angioplasty (PTA) serration balloon catheter for chronic limb-threatening ischaemia (CLTI) and pedal disease. A press release notes that Serranator SL-PRO utilises Cagent’s proven serration technology on a redesigned platform, offering improved deliverability and trackability, while offering Serranator’s proven 1,000 times increase in …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Interventional News broke the news in on Tuesday, February 4, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
Search
BlindspotLocal